PDS Biotechnology Corporation (PDSB)

PDS Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	49.75	56.56	73.82	65.24	28.84	12.16
Cash & Short-Term Investments	49.75	56.56	73.82	65.24	28.84	12.16
Cash Growth	-8.29%	-23.38%	13.15%	126.23%	137.13%	11628.38%
Prepaid Expenses	2.38	2.49	2.66	1.6	1.5	2.31
Total Current Assets	52.13	59.06	76.48	66.84	30.34	14.47
Property, Plant & Equipment	0.32	0.34	0.53	0.36	0.55	0.02
Total Assets	52.45	59.39	77.01	67.2	30.89	14.49
Accounts Payable	1.3	6.98	1.22	1.31	1.42	1.2
Accrued Expenses	4.48	2.42	8.31	2.19	1.74	1.1
Short-Term Debt	12.5	4.17	-	-	-	-
Current Portion of Leases	0.06	0.06	0.29	0.26	0.12	-
Other Current Liabilities	-	-	-	-	-	0.5
Total Current Liabilities	18.34	13.63	9.82	3.76	3.27	2.79
Long-Term Debt	12.03	19.51	23.02	-	-	-
Long-Term Leases	0.08	0.12	0.16	0.23	0.49	-
Total Liabilities	30.45	33.26	33.01	3.99	3.76	2.79
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	196.15	170.62	145.55	123.9	70.91	40.63
Retained Earnings	-174.16	-144.5	-101.56	-60.7	-43.79	-28.94
Shareholders' Equity	22	26.13	44	63.21	27.13	11.7
Total Liabilities & Equity	52.45	59.39	77.01	67.2	30.89	14.49
Total Debt	24.67	23.85	23.47	0.49	0.61	-
Net Cash (Debt)	25.08	32.71	50.35	64.75	28.23	12.16
Net Cash Growth	-18.16%	-35.03%	-22.25%	129.38%	132.12%	16402.80%
Net Cash Per Share	0.72	1.06	1.76	2.53	1.69	2.50
Filing Date Shares Outstanding	37.41	36.68	30.72	28.45	22.26	5.28
Total Common Shares Outstanding	36.82	33.09	30.17	28.45	22.26	5.28
Working Capital	33.79	45.43	66.66	63.08	27.07	11.68
Book Value Per Share	0.60	0.79	1.46	2.22	1.22	2.21
Tangible Book Value	22	26.13	44	63.21	27.13	11.7
Tangible Book Value Per Share	0.60	0.79	1.46	2.22	1.22	2.21
Machinery	-	0.27	0.12	0.12	0.12	0.12

Source: S&P Capital IQ. Standard template. Financial Sources.